Risks associated with hyperkalemia
Video navigation menu
- Definition of hyperkalemia 01:03
- Major causes of hyperkalemia 02:44
- Problems and risks associated with hyperkalemia 04:10
- Hyperkalemia is associated with submaximal dose or discontinuation of RAASi 05:50
This lecture by Stefan Anker was part of an accredited symposium "Potassium binding in heart failure management - Enabling guideline-recommended RAASi therapy" held during the virtual ESC Congress 2021.
Prof. Stefan Anker, MD, PhD is Head of Field “Tissue Homeostasis and Cachexia" at Charité University, Berlin, Germany.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Vifor Pharma.